The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this “Connectivity Map” resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, post-perturbation transcriptomics data are particularly suited for training computational models because the causal relationship between known perturbations (cause) and the measured post-perturbation gene expression (effect) allows for the modelling of mechanistic processes [11].”
From Benchmarking foundation cell models for post-perturbation RNA-seq prediction (2025) · cites this paper as [11]
In the citing paper
“Both Alakwaa’ and Luo’s pipelines use the CLUE platform, a cloud-based platform developed by the LINCS Center for signature-gene based drug ranking61.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [61]
In the citing paper
“For example, in a classic paradigm inflammatory bowel disease (IBD) signatures were derived from surgical specimens and intersected with Connectivity Map70 data representing transcriptional readouts across a number of cell lines in response to treatment with many hundreds of drugs using a novel pattern-matching algorithm71. From this research the anticonvulsant drug topiramate was identified and”
From Exploiting machine learning for end-to-end drug discovery and development (2019) · cites this paper as [71]
In the citing paper
“Useful tools will include maps of evolutionary conservation (108) and chromatin state (140), as well as databases of cell-state signatures, such as genome-wide expression patterns, that may integrate aspects of cell biology under resting and provoked conditions (141).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [141]
In the citing paper
“It has been shown that compounds eliciting similar transcriptional signatures tend to share mechanisms of action.170,207−209”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [207]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Research works printed but not linked: 7
- K. B. Glaser et al., Mol. Cancer Ther.2, 151 (2003).
- A. E. Wakeling, M. Dukes, J. Bowler, Cancer Res.51, 3867 (1991).
- J. Y. Vanderhoek, M. B. Feinstein, Mol. Pharmacol.16, 171 (1979).
- H. Hieronymus et al. Cancer Cell in press.
- Q. Yao et al., Clin. Cancer Res.9, 4483 (2003).
- T. Kubota et al., Cancer Res.58, 3344 (1998).
- G. Wei et al. Cancer Cell in press.
Cited by
Items 301–400 of 1,037
Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers
Chen, E. Y., Xu, H., Gordonov, S., Lim, M. P., Perkins, M. H., & Ma'ayan, A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/btr625 · Cited by 180
Yang, C. G., Zhang, H., Chen, M., Wang, S., Qian, R., Zhang, L., Huang, X., Wang, J., Liu, Z., Qin, W., et al. (2022) · eLife · doi:10.7554/elife.71880 · Cited by 180
Su, Z., Fang, H., Hong, H., Shi, L., Zhang, W., Zhang, W., Zhang, Y., Dong, Z., Lancashire, L. J., Bessarabova, M., et al. (2014) · Genome Biology · doi:10.1186/s13059-014-0523-y · Cited by 179
DrugComboRanker: drug combination discovery based on target network analysis
Huang, L., Li, F., Sheng, J., Xia, X., Ma, J., Zhan, M., & Wong, S. T. C. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu278 · Cited by 178
Bruno, P. M., Lu, M., Dennis, K. A., Inam, H., Moore, C. J., Sheehe, J., Elledge, S. J., Hemann, M. T., & Pritchard, J. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921649117 · Cited by 175
Huang, J., Niu, C., Green, C. D., Yang, L., Mei, H., & Han, J. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002998 · Cited by 175
Mav, D., Shah, R. R., Howard, B. E., Auerbach, S. S., Bushel, P. R., Collins, J. B., Gerhold, D. L., Judson, R. S., Karmaus, A. L., Maull, E. A., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191105 · Cited by 155
McFarland, J. M., Paolella, B. R., Warren, A., Geiger-Schuller, K., Shibue, T., Rothberg, M., Kuksenko, O., Colgan, W. N., Jones, A., Chambers, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17440-w · Cited by 173
Self-citationEffects of Cigarette Smoke on the Human Oral Mucosal Transcriptome
Boyle, J. O., Gümüş, Z. H., Kacker, A., Choksi, V. L., Bocker, J. M., Zhou, X. K., Yantiss, R. K., Hughes, D. B., Du, B., Judson, B. L., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0192 · Cited by 173
Lehár, J., Stockwell, B. R., Giaever, G., & Nislow, C. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.120 · Cited by 172
Identification of disease treatment mechanisms through the multiscale interactome
Ruiz, C., Zitnik, M., & Leskovec, J. (2021) · Nature Communications · doi:10.1038/s41467-021-21770-8 · Cited by 172
“To validate drug diffusion 671 profiles, we compare drug diffusion profiles to the drug gene expression signatures present in the 672 Broad Connectivity Map [48, 49] (Figure 2f).”
BackgroundMethodRepurposing of drugs: An attractive pharmacological strategy for cancer therapeutics
Kirtonia, A., Gala, K., Fernandes, S. G., Pandya, G., Pandey, A. K., Sethi, G., Khattar, E., & Garg, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.04.006 · Cited by 172
Zhao, W., Prijic, S., Urban, B. C., Tisza, M. J., Zuo, Y., Li, L., Tan, Z., Chen, X., Mani, S. A., & Chang, J. T. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1970 · Cited by 172
Takata, A., Miyake, N., Tsurusaki, Y., Fukai, R., Miyatake, S., Koshimizu, E., Kushima, I., Okada, T., Morikawa, M., Uno, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.074 · Cited by 172
Molecular signatures associated with ZIKV exposure in human cortical neural progenitors
Zhang, F., Hammack, C., Ogden, S. C., Cheng, Y., Lee, E. M., Wen, Z., Qian, X., Nguyen, H. N., Li, Y., Yao, B., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw765 · Cited by 171
Connecting omics signatures and revealing biological mechanisms with iLINCS
Pilarczyk, M., Fazel-Najafabadi, M., Kouril, M., Shamsaei, B., Vasiliauskas, J., Niu, W., Mahi, N., Zhang, L., Clark, N. A., Ren, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32205-3 · Cited by 153
Cross‐species chemogenomic profiling reveals evolutionarily conserved drug mode of action
Kapitzky, L., Beltrao, P., Berens, T. J., Gassner, N., Zhou, C., Wüster, A., Wu, J., Babu, M. M., Elledge, S. J., Toczyski, D., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.107 · Cited by 170
Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment
Wetmore, B. A. (2015) · Toxicology · doi:10.1016/j.tox.2014.05.012 · Cited by 170
Learning therapeutic lessons from metastasis suppressor proteins
Smith, S. C., & Theodorescu, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2594 · Cited by 170
Machine learning and image-based profiling in drug discovery
Scheeder, C., Heigwer, F., & Boutros, M. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.05.004 · Cited by 169
Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes
Schreiber, S. L., Kotz, J. D., Li, M., Aubé, J., Austin, C. P., Reed, J. C., Rosen, H., White, E. L., Sklar, L. A., Lindsley, C. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.023 · Cited by 169
Self-citationFrom prenatal genomic diagnosis to fetal personalized medicine: progress and challenges
Bianchi, D. W. (2012) · Nature Medicine · doi:10.1038/nm.2829 · Cited by 169
Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug
Zhang, X., Selvaraju, K., Saei, A. A., D'Arcy, P., Zubarev, R. A., Arnér, E. S., & Linder, S. (2019) · Biochimie · doi:10.1016/j.biochi.2019.03.015 · Cited by 169
Kim, H., Kim, E., Lee, I., Bae, B., Park, M., & Nam, H. (2020) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-020-0049-y · Cited by 131
Applications in image-based profiling of perturbations
Caicedo, J. C., Singh, S., & Carpenter, A. E. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.04.003 · Cited by 168
Defining principles of combination drug mechanisms of action
Pritchard, J. R., Bruno, P. M., Gilbert, L. A., Capron, K. L., Lauffenburger, D. A., & Hemann, M. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210419110 · Cited by 168
“Additionally, mammalian transcriptional data have also been used to determine the mechanisms of small molecule action (15, 16).”
MethodHait, W. N., & Hambley, T. W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3836 · Cited by 168
Covington, B. C., McLean, J. A., & Bachmann, B. O. (2017) · Natural Product Reports · doi:10.1039/c6np00048g · Cited by 150
Identification and Application of Gene Expression Signatures Associated with Lifespan Extension
Tyshkovskiy, A., Bozaykut, P., Borodinova, A. A., Gerashchenko, M. V., Ables, G. P., Garratt, M., Khaitovich, P., Clish, C. B., Miller, R. A., & Gladyshev, V. N. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.018 · Cited by 167
Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models
Zhang, T., Zhang, L., Payne, P. R. O., & Li, F. (2021) · Methods in Molecular Biology · doi:10.1007/978-1-0716-0849-4_12 · Cited by 167
Proteomic and Genetic Approaches Identify Syk as an AML Target
Hahn, C. K., Berchuck, J. E., Ross, K. N., Kakoza, R. M., Clauser, K., Schinzel, A. C., Ross, L., Galinsky, I., Davis, T. N., Silver, S. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.018 · Cited by 167
Self-citationJeon, J., Nim, S., Teyra, J., Datti, A., Wrana, J. L., Sidhu, S. S., Moffat, J., & Kim, P. M. (2014) · Genome Medicine · doi:10.1186/preaccept-8096551512514564 · Cited by 166
Assessing Drug Target Association Using Semantic Linked Data
Chen, B., Ding, Y., & Wild, D. J. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002574 · Cited by 166
“We took all the 164 small molecules from the Connectivity Map (CMap), an online dataset mapping relationships of disease profiles to known drugs [18], and 113 molecules that were mapped to our network were used to build a library.”
BackgroundMethodChanging Trends in Computational Drug Repositioning
Yella, J. K., Yaddanapudi, S., Wang, Y., & Jegga, A. G. (2018) · Pharmaceuticals · doi:10.3390/ph11020057 · Cited by 166
Brandt, G. E. L., Schmidt, M. D., Prisinzano, T. E., & Blagg, B. S. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8007486 · Cited by 166
Genome-Wide Significant Loci: How Important Are They?
Björkegren, J. L. M., Kovacic, J. C., Dudley, J. T., & Schadt, E. E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.033 · Cited by 141
Computational drug repositioning through heterogeneous network clustering
Wu, C., Gudivada, R. C., Aronow, B. J., & Jegga, A. G. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-s5-s6 · Cited by 152
PharmKG: a dedicated knowledge graph benchmark for bomedical data mining
Zheng, S., Rao, J., Song, Y., Zhang, J., Xiao, X., Fang, E. F., Yang, Y., & Niu, Z. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa344 · Cited by 165
Wang, S. E., Xiang, B., Guix, M., Olivares, M. G., Parker, J., Chung, C. H., Pandiella, A., & Arteaga, C. L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00787-08 · Cited by 165
Comprehensive Survey of Recent Drug Discovery Using Deep Learning
Kim, J., Park, S., Min, D., & Kim, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189983 · Cited by 167
Bredholt, G., Mannelqvist, M., Stefansson, I. M., Birkeland, E., Bø, T. H., Øyan, A. M., Trovik, J., Kalland, K.-H., Jonassen, I., Salvesen, H. B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5344 · Cited by 164
Systematic morphological profiling of human gene and allele function via Cell Painting
Rohban, M. H., Singh, S., Wu, X., Berthet, J. B., Bray, M.-A., Shrestha, Y., Varelas, X., Boehm, J. S., & Carpenter, A. E. (2017) · eLife · doi:10.7554/elife.24060 · Cited by 164
Identifying compound efficacy targets in phenotypic drug discovery
Schirle, M., & Jenkins, J. L. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.08.001 · Cited by 164
Vilar, E., Bartnik, C. M., Stenzel, S. L., Raskin, L., Ahn, J., Moreno, V., Mukherjee, B., Iniesta, M. D., Morgan, M. A., Rennert, G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1120 · Cited by 150
Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds
Bruni, G. N., Rennekamp, A. J., Velenich, A., McCarroll, M. N., Gendelev, L., Fertsch, E., Taylor, J. C., Lakhani, P., Lensen, D., Evron, T., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2097 · Cited by 164
Drug repurposing for breast cancer therapy: Old weapon for new battle
Aggarwal, S., Verma, S. S., Aggarwal, S., & Gupta, S. C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.012 · Cited by 163
Structure-based systems biology for analyzing off-target binding
Xie, L., Xie, L., & Bourne, P. E. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.01.004 · Cited by 166
Distinct longevity mechanisms across and within species and their association with aging
Tyshkovskiy, A., Ma, S., Shindyapina, A. V., Tikhonov, S., Lee, S.-G., Bozaykut, P., Castro, J. P., Seluanov, A., Schork, N. J., Gorbunova, V., et al. (2023) · Cell · doi:10.1016/j.cell.2023.05.002 · Cited by 162
The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum
Piechota, M., Korostynski, M., Solecki, W., Gieryk, A., Slezak, M., Bilecki, W., Ziolkowska, B., Kostrzewa, E., Cymerman, I., Swiech, L., et al. (2010) · Genome Biology · doi:10.1186/gb-2010-11-5-r48 · Cited by 162
Network-based drug repositioning
Wu, Z., Wang, Y., & Chen, L. (2013) · Molecular BioSystems · doi:10.1039/c3mb25382a · Cited by 162
Anticancer Inhibitors of Hsp90 Function
(2016) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.12.001 · Cited by 146
Chang, J., Kim, Y., & Kwon, H. J. (2016) · Natural Product Reports · doi:10.1039/c5np00107b · Cited by 162
An update on Drug Repurposing: Re-written saga of the drug’s fate
GNS, H. S., GR, S., Murahari, M., & Krishnamurthy, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.127 · Cited by 161
Balan, S., Arnold-Schrauf, C., Abbas, A., Couespel, N., Savoret, J., Imperatore, F., Villani, A.-C., Vu Manh, T.-P., Bhardwaj, N., & Dalod, M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.033 · Cited by 161
Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids
Mao, Y., Wang, W., Yang, J., Zhou, X., Lu, Y., Gao, J., Wang, X., Wen, L., Fu, W., & Tang, F. (2023) · Protein & Cell · doi:10.1093/procel/pwad038 · Cited by 162
Saito, S., Furuno, A., Sakurai, J., Sakamoto, A., Park, H.-R., Shin-ya, K., Tsuruo, T., & Tomida, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2689 · Cited by 160
Drug-Induced Regulation of Target Expression
Iskar, M., Campillos, M., Kuhn, M., Jensen, L. J., van Noort, V., & Bork, P. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000925 · Cited by 142
Using the Heat-Shock Response To Discover Anticancer Compounds that Target Protein Homeostasis
Santagata, S., Xu, Y.-M., Wijeratne, E. M. K., Kontnik, R., Rooney, C., Perley, C. C., Kwon, H., Clardy, J., Kesari, S., Whitesell, L., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb200353m · Cited by 147
Bioinformatics Approaches for Anti-cancer Drug Discovery
Li, K., Du, Y., Li, L., & Wei, D. (2019) · Current Drug Targets · doi:10.2174/1389450120666190923162203 · Cited by 164
Proteomic methods for drug target discovery
Sleno, L., & Emili, A. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.01.022 · Cited by 160
Systems biology approaches for advancing the discovery of effective drug combinations
Ryall, K. A., & Tan, A. C. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0055-9 · Cited by 159
A multichannel nanosensor for instantaneous readout of cancer drug mechanisms
Rana, S., Le, N. D. B., Mout, R., Saha, K., Tonga, G. Y., Bain, R. E. S., Miranda, O. R., Rotello, C. M., & Rotello, V. M. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2014.285 · Cited by 159
Targeting MTHFD2 in acute myeloid leukemia
Pikman, Y., Puissant, A., Alexe, G., Furman, A., Chen, L. M., Frumm, S. M., Ross, L., Fenouille, N., Bassil, C. F., Lewis, C. A., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151574 · Cited by 159
Nutritional Systems Biology Modeling: From Molecular Mechanisms to Physiology
de Graaf, A. A., Freidig, A. P., De Roos, B., Jamshidi, N., Heinemann, M., Rullmann, J. A. C., Hall, K. D., Adiels, M., & van Ommen, B. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000554 · Cited by 153
Oulas, A., Minadakis, G., Zachariou, M., Sokratous, K., Bourdakou, M. M., & Spyrou, G. M. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx151 · Cited by 160
Costa, B. M., Smith, J. S., Chen, Y., Chen, J., Phillips, H. S., Aldape, K. D., Zardo, G., Nigro, J., James, C. D., Fridlyand, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2189 · Cited by 158
“for drugs that induce gene expression signatures involving HOXA9-associated genes (33).”
BackgroundTAZ Expression as a Prognostic Indicator in Colorectal Cancer
Yuen, H.-F., McCrudden, C. M., Huang, Y.-H., Tham, J. M., Zhang, X., Zeng, Q., Zhang, S.-D., & Hong, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054211 · Cited by 158
“expression of genes that are co-regulated in TAZ-AXL-CTGF coexpressing aggressive colon cancer [39,40,41].”
BackgroundMethodInfluentialWik, E., Ræder, M. B., Krakstad, C., Trovik, J., Birkeland, E., Hoivik, E. A., Mjos, S., Werner, H. M. J., Mannelqvist, M., Stefansson, I. M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3039 · Cited by 136
Bhatla, T., Wang, J., Morrison, D. J., Raetz, E. A., Burke, M. J., Brown, P. A., & Carroll, W. L. (2012) · Blood · doi:10.1182/blood-2012-01-401687 · Cited by 158
Lindqvist, R., Mundt, F., Gilthorpe, J. D., Wölfel, S., Gekara, N. O., Kröger, A., & Överby, A. K. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0748-7 · Cited by 143
Effects of hypoxia on human cancer cell line chemosensitivity
Strese, S., Fryknäs, M., Larsson, R., & Gullbo, J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-331 · Cited by 136
Current Screening Methodologies in Drug Discovery for Selected Human Diseases
Lage, O. M., Ramos, M. C., Calisto, R., Almeida, E., Vasconcelos, V. M., & Vicente, F. (2018) · Marine Drugs · doi:10.3390/md16080279 · Cited by 157
Diversity of meso-scale architecture in human and non-human connectomes
Betzel, R. F., Medaglia, J. D., & Bassett, D. S. (2018) · Nature Communications · doi:10.1038/s41467-017-02681-z · Cited by 157
Liu, C., Dong, W. G., Xiang, J., Ren, F., Huang, L., Lang, J., Tian, G., Li, Y., & Yang, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.07.003 · Cited by 157
Terazosin activates Pgk1 and Hsp90 to promote stress resistance
Chen, X., Zhao, C., Li, X., Wang, T., Li, Y., Cao, C., Ding, Y., Dong, M., Finci, L., Wang, J.-H., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1657 · Cited by 156
Chang, C., Kazmin, D. A., Jasper, J. S., Kunder, R. S., Zuercher, W. J., & McDonnell, D. P. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.023 · Cited by 157
Tools for in silico target fishing
Cereto‐Massagué, A., Ojeda, M. J., Valls, C., Mulero, M., Pujadas, G., & García-Vallvé, S. (2014) · Methods · doi:10.1016/j.ymeth.2014.09.006 · Cited by 156
Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis
Patwardhan, C. A., Fauq, A. H., Peterson, L. B., Miller, C. A., Blagg, B. S. J., & Chadli, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.427328 · Cited by 156
Jovanović, B., Mayer, I. A., Mayer, E. L., Abramson, V. G., Bardia, A., Sanders, M. E., Kuba, M. G., Estrada, M. V., Beeler, J. S., Shaver, T. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3055 · Cited by 159
PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies
Smirnov, P., Kofia, V., Maru, A., Freeman, M., Ho, C., El-Hachem, N., Adam, G.-A., Ba-alawi, W., Safikhani, Z., & Haibe-Kains, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx911 · Cited by 155
Kang, S., Dong, S. M., Kim, B.-R., Park, M. S., Trink, B., Byun, H.-J., & Rho, S. B. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0717-2 · Cited by 155
Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma
Chen, B., Garmire, L., Calvisi, D. F., Chua, M.-S., Kelley, R. K., & Chen, X. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0240-9 · Cited by 154
Zhu, H., Zhang, J., Kim, M. T., Boison, A., Sedykh, A., & Moran, K. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500145h · Cited by 154
Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species?
Reynolds, G., & Haniffa, M. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00330 · Cited by 155
A survey of yeast genomic assays for drug and target discovery
Smith, A. M., Ammar, R., Nislow, C., & Giaever, G. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.012 · Cited by 133
In silico prediction of novel therapeutic targets using gene–disease association data
Ferrero, E., Dunham, I., & Sanseau, P. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1285-6 · Cited by 130
Big data in IBD: a look into the future
Olivera, P., Danese, S., Jay, N., Natoli, G., & Peyrin-Biroulet, L. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0102-5 · Cited by 151
Analysis of Cell Fate from Single-Cell Gene Expression Profiles in C. elegans
Liu, X., Long, F., Peng, H., Aerni, S. J., Jiang, M., Sánchez-Blanco, A., Murray, J. I., Preston, E. A., Mericle, B., Batzoglou, S., et al. (2009) · Cell · doi:10.1016/j.cell.2009.08.044 · Cited by 151
Why imaging data alone is not enough: AI-based integration of imaging, omics, and clinical data
Holzinger, A., Haibe‐Kains, B., & Jurišica, I. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04382-9 · Cited by 152
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
Torre, C. F., Jiménez‐Santos, M. J., García‐Martín, S., Carretero-Puche, C., García-Jimeno, L., Ivanchuk, V., Domenico, T. D., Goméz-López, G., & Al‐Shahrour, F. (2021) · Genome Medicine · doi:10.1186/s13073-021-01001-x · Cited by 151
Next Generation Gold Drugs and Probes: Chemistry and Biomedical Applications
Mertens, R. T., Gukathasan, S., Arojojoye, A. S., Olelewe, C., & Awuah, S. G. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00649 · Cited by 151
Design of efficient computational workflows for in silico drug repurposing
Vanhaelen, Q., Mamoshina, P., Aliper, A. M., Artemov, A., Lezhnina, K., Ozerov, I., Labat, I., & Zhavoronkov, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.019 · Cited by 150
Rubio-Viqueira, B., & Hidalgo, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.200 · Cited by 134
Costa, P. M., & Fadeel, B. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.014 · Cited by 150
Complex scaffold remodeling in plant triterpene biosynthesis
Peña, R. D. L., Hodgson, H., Liu, C., Stephenson, M. J., Martín, A. C., Owen, C., Harkess, A., Leebens‐Mack, J., Jimenez, L. E., Osbourn, A., et al. (2023) · Science · doi:10.1126/science.adf1017 · Cited by 150
Klami, A., Virtanen, S., Leppaaho, E., & Kaski, S. (2015) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2014.2376974 · Cited by 101
Mo, W., Liu, Q., Lin, C. C.-J., Dai, H., Peng, Y., Liang, Y., Peng, G., Meric-Bernstam, F., Mills, G. B., Li, K., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1772 · Cited by 136
Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry
So, H., Chau, C. K., Chiu, W.-T., Ho, K.-S., Lo, C.-P., Yim, S. H.-Y., & Sham, P. C. (2017) · Nature Neuroscience · doi:10.1038/nn.4618 · Cited by 149
Alexander-Dann, B., Pruteanu, L.-L., Oerton, E., Sharma, N., Berindan‐Neagoe, I., Módos, D., & Bender, A. (2018) · Molecular Omics · doi:10.1039/c8mo00042e · Cited by 149
Tan, B. S., Tiong, K. H., Choo, H. L., Fei-Lei Chung, F., Hii, L.-W., Tan, S. H., Yap, I. K., Pani, S., Khor, N. T., Wong, S. F., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.191 · Cited by 136
Metadata
- Authors
- Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Crawford, Emily D.
- Golub, Todd R.
- ORCID
- Venue
- Science
- Published
- 2006-09-29
- Volume
- 313
- Issue
- 5795
- Pages
- 1929-1935
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2121604817
- Cited by
- 5,257
- References
- 41
- Citations by year
- 2026: 226 · 2025: 285 · 2024: 332 · 2023: 370 · 2022: 416 · 2021: 406 · 2020: 383 · 2019: 385 · 2018: 280 · 2017: 288 · 2016: 296 · 2015: 259 · 2014: 217 · 2013: 241 · 2012: 219
- FWCI
- 118.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene expression signatures, small molecules, drug action, gene perturbation, mechanism of action, cultured human cells, functional genomics
- MeSH terms
- Alzheimer Disease, Cell Line, Dexamethasone, Drug Evaluation, Preclinical, Enzyme Inhibitors, Estrogens, Humans, Obesity, Phenothiazines, Software, Gene Expression, Databases, Factual, HSP90 Heat-Shock Proteins, Drug Resistance, Neoplasm, Sirolimus, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Limonins, Cell Line, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.